Sift Biosciences
AI-driven immunotherapy boosters enhancing cancer treatment efficacy and patient survival.
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
| Total Funding | 000k | ||
Sift Biosciences operates in the biotechnology sector, focusing on enhancing cancer therapies through the development of immunotherapy boosters. Utilizing artificial intelligence and high throughput cellular screening, the company designs solutions aimed at significantly extending the survival rates of cancer patients. Sift Biosciences targets healthcare providers and research institutions seeking advanced treatment options. The business model likely involves partnerships with pharmaceutical companies and healthcare organizations, generating revenue through licensing agreements and collaborative research projects. By integrating cutting-edge technology with medical research, Sift Biosciences positions itself as a key player in the oncology treatment landscape.
Keywords: immunotherapy, AI, cancer, boosters, cellular screening, survival, biotechnology, healthcare, oncology, treatment.